Suchergebnisse - "Dal-Ré, Rafael"

PubPharm (26)

1

Is full transparency in clinical trials an achievable goal?

enthalten in: European journal of internal medicine | 2024

von Dal-Ré, R.

2

The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans

enthalten in: Therapie | 2023

von Dal-Ré, R.

3

Waivers of informed consent in research with competent participants and the Declaration of Helsinki

enthalten in: European journal of clinical pharmacology | 2023

von Dal-Ré, R.

4

Waivers of informed consent in research with competent participants and the Declaration of Helsinki

enthalten in: European journal of clinical pharmacology | 2023

von Dal-Ré, R.

5

US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine

enthalten in: Vaccine | 2021

von Dal-Ré, R.

6

Participant-funded clinical trials on rare diseases

enthalten in: Anales de pediatria | 2020

von Dal-Ré, R. | Palau, F. | Guillén-Navarro, E. | +1

7

Participant-funded clinical trials on rare diseases

enthalten in: Anales de pediatria | 2020

von Dal-Ré, R. | Palau, F. | Guillén-Navarro, E. | +1

8

The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features

enthalten in: Journal of clinical epidemiology | 2020

von Dal-Ré, R. | de Boer, A. | James, S.

9

Clinical trials : generalizability is much more than representativeness

enthalten in: European journal of internal medicine | 2020

von Dal-Ré, R.

CommentOn: JAMA Intern Med. 2020 May 1;180(5):795-797. - PMID 32176252

10

Efficacy and effectiveness : The wrong use of different terms

enthalten in: European journal of internal medicine | 2018

von Dal-Ré, R. | Rosendaal, F.